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Kytococcus
schroeteri
Endocarditis
To the Editor: Becker et al. recent-
ly reported the probable implication of
Kytococcus schroeteri in a case of
acute prosthetic valve endocarditis, on
the basis of its recovery from blood
cultures drawn at the time of infection
(1). K. schroeteri was only character-
ized on that occasion and is a new
micrococcal species resistant to peni-
cillins (2). Here, we report the isola-
tion of this organism from prosthetic
valve vegetations in a patient who had
undergone aortic valve replacement 3
years earlier. The 73-year-old man was
admitted with fever (38.8°C) and
shortness of breath, which had both
increased gradually over the previous
2 months. He had no recent history of
intravenous drug administration or
catheterization. Laboratory findings
showed a leukocyte count of 12 x
109/L (90% neutrophils) and a raised
C-reactive protein level. Transeso-
phageal echocardiogram revealed sev-
eral small vegetations on the
Carpentier-Edwards aortic bioprosthe-
sis and a voluminous perivalvular
abscess. Four sets of blood cultures
were drawn before antimicrobial ther-
apy was initiated.
Intravenous vancomycin (2 g twice
a day) and gentamicin (240 mg/d)
were started empirically. The prosthet-
ic material was replaced promptly and
the abscess was debrided extensively.
Vegetations from the resected material
showed numerous polymorphonuclear
neutrophils and gram-positive cocci
on microscopic examination. Oral
rifampicin (600 mg twice a day) was
added to the initial regimen.
The postoperative course was
uneventful except for cutaneous intol-
erance to vancomycin, which was
replaced with teicoplanin. The physi-
cal condition of the patient improved
steadily. Gentamicin and rifampicin
were discontinued after 3 weeks.
Eight months after completion of the
6-week treatment, the patient had no
clinical or biologic evidence of infec-
tion, although moderate aortic incom-
petence persisted.
All blood cultures drawn on
admission grew gram-positive cocci
after 72 hours and subcultures on
Trypticase soy agar yielded convex,
muddy-yellow colonies of heteroge-
neous sizes. The vegetations, pus
samples of the abscess, and prosthetic
valve cultures grew the same type of
colonies. All isolates displayed identi-
cal biotype and antimicrobial suscep-
tibility and were considered as a sin-
gle strain. The causative organism
(designated ROG140) was initially
identified as Micrococcus sp. based
on the morphologic features, resist-
ance to nitrofurantoin, and inability to
grow anaerobically. Assignment to the
genus Kytococcus was suggested by
the arginine dihydrolase activity and
resistance to oxacillin, 2 characteris-
tics that are not shared by other micro-
cocci (3).
The definitive K. schroeteri identi-
fication was provided by analysis of
the fatty acid content, which was sim-
ilar to that of the type strain (2), and
sequencing of the 16S rRNA genes.
Figure. (A) Phylogenetic tree showing relationships among 16S rDNA sequences of clini-
cal isolate ROG140 and type strains of members of the former Micrococcus genus.
Nocardia asteroides was included as an out-group organism. The scale bar represents 1%
differences in nucleotide sequences. (B) Sequence alignment of 16S rDNA nucleotides
983-992 and 1003-1014 of Kytococcus sp. type strains (TS) and clinical isolate ROG140.
K. schroeteri molecular signatures are boxed. Nucleotide numbering refers to the
sequence of the 16S rDNA of E. coli.LETTERS
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We sequenced a 1,012-bp fragment
encompassing the first two thirds of
the 16S rDNA of ROG140 (accession
no. AY692224). The sequence was
compared with those of type strains of
all members of the former genus
Micrococcus, and a phylogenetic tree
was deduced by the neighbor–joining
method (Figure). The sequences of
ROG140 and the K. schroeteri type
strain only differ by an A-to-G substi-
tution at position 747 (E. coli number-
ing). Among the 21 nucleotide differ-
ences between the sequences of K.
schroeteri and the closely related
species K. sedentarius, 10 are located
on a 30-base stretch and constitute a
convenient  K. schroeteri signature
(Figure)
Antimicrobial susceptibility testing
performed with the disk diffusion
method and Etests (AB Biodisk,
Solna, Sweden) indicated that the iso-
late was resistant to penicillins,
cephalosporins, kanamycin, tobra-
mycin, erythromycin, clindamycin,
sulfonamides, and fusidic acid, but
susceptible to imipenem (MIC, 0.25
µg/mL), gentamicin (MIC, 1 µg/mL),
trimethoprim (MIC, 0.25 µg/mL),
tetracycline (MIC, 0.12 µg/mL), line-
zolid (MIC, 0.25 µg/mL), vancomycin
(MIC, 0.125 µg/mL), teicoplanin
(MIC, 0.06 µg/mL), and rifampicin
(MIC,  <0.002  µg/mL). Unlike the
original isolate reported by Becker et
al. (1), isolate ROG140 was resistant
to ofloxacin and ciprofloxacin (MICs,
8  µg/mL). Conversely, moxifloxacin
displayed excellent in vitro activity
(MIC, 0.05 µg/mL). As moxifloxacin
was more rapidly microbicidal than
vancomycin in an animal model of
Staphylococcus aureus prosthetic
valve endocarditis (4), it might present
a potential advantage against infec-
tions caused by K. schroeteri, espe-
cially when the oral route is favored.
The natural habitat of K. schroeteri
remains unknown. The only isolates
of K. schroeteri identified so far orig-
inated from blood or cardiac material,
although  Kytococcus literally means
“a coccus from the skin.” Our
attempts to recover K. schroeteri from
the mouth, nose, or skin of our patient
were unsuccessful. In a recent study,
Szczerba et al. were able to isolate
most micrococcal species, including
K. sedentarius but not K. schroeteri,
from human skin and mucosa (5).
However, at that time the authors may
not have been aware of this newly
described species. The mode of con-
tamination also remains unclear. In
the original description (1), K. schroe-
teri endocarditis had developed in the
patient <3 months after she underwent
cardiac surgery, which suggested peri-
operative contamination. Here, we
describe a late onset, subacute infec-
tion 3 years after surgery, which is
more likely to have been caused by
hematogenous spread.
Although Micrococcus-like organ-
isms cause endocarditis infrequently
(6), the description of 2 independent
infections due to a new species in a
short period is intriguing and suggests
a specific pathogenicity, at least on
prosthetic heart devices. By demon-
strating the presence of the bacteria in
the infected site, this report establishes
K. schroeteri as a genuine pathogen in
this clinical setting and should prompt
further investigations to identify its
natural habitat and virulence determi-
nants. At present, commercial systems
are not able to identify K. schroeteri.
However, gram-positive cocci that are
strictly aerobic, oxacillin-resistant, and
arginine dihydrolase-positive should
be recognized as potential Kytococcus
species and taken into account when
endocarditis is suspected.
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Viral
Gastroenteritis in
Mongolian Infants 
To the Editor: Viral agents of gas-
troenteritis affect millions of persons
of all ages worldwide (1). The major
agents include rotavirus, norovirus,
sapovirus, astrovirus, and enteric ade-
novirus. Rotavirus is the most fre-
quent cause of acute sporadic child-
hood gastroenteritis (1), whereas
norovirus infects both adults and chil-
dren and is mainly associated with